Loading...
NPI 1457390353 · Ft Walton Beach, FL · Medical Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Yunhui Hsiang is a medical oncology physician provider located in Ft Walton Beach, Florida. This profile covers 52 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Yunhui Hsiang |
| Address | 1024 Mar Walt Dr |
| City | Ft Walton Beach |
| State | FL |
| ZIP | 32547 |
| Taxonomy | Medical Oncology Physician |
| NPI Enumerated | June 6, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.6M |
| Medicaid | $1.3K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
52 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 39,600 | $40 | $1.7M |
| J0897 | Injection, denosumab, 1 mg | 31,740 | $20 | $571.3K |
| J9311 | Injection, rituximab 10 mg and hyaluronidase | 11,340 | $30 | $328.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,330 | $100 | $130.5K |
| J9312 | Injection, rituximab, 10 mg | 1,960 | $60 | $125.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,650 | $70 | $107.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 1,000 | $100 | $97.5K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 88,500 | $1 | $88.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 420 | $140 | $58.4K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,600 | $20 | $44.2K |
Showing 1–10 of 52
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 52 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
52 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 7 | 210 | 16,100 | $40 | $802.7K |
| J9311 | 1 | 10 | 11,340 | $30 | $331.5K |
| J9312 | 27 | 30 | 3,730 | $60 | $253.2K |
| J0897 | 12 | 1,060 | 3,290 | $20 | $106.5K |
| J1437 | 59 | 110 | 2,700 | $20 | $59.9K |
| J0885 | 138 | 240 | 6,630 | $10 | $45.6K |
| J1439 | 6 | 100 | 24,750 | $1 | $29.5K |
| Q5106 | 36 | 110 | 3,030 | $10 | $26.7K |
| 96413 | 13 | 730 | 200 | $100 | $26.1K |
| 99214 | 1,016 | 32,760 | 140 | $90 | $25K |
Showing 1–10 of 52
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 260 | $1 | $790 |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 20 | $1 | $50 |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 110 | $0 | $0 |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 1,210 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 3,511 | 5,930 | 460 | $40 | $169.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 5,894 | 6,380 | 430 | $50 | $139.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 435 | 820 | 1,430 | $1 | $92.8K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 895 | 1,330 | 340 | $10 | $54.3K |
Other providers in the same ZIP code as Yunhui Hsiang, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.